Special attractions for suppressor T cells

Trends in Immunology

Volumn 24, Issue 3, 2003, Pages 122-126

  D'Ambrosio, Daniele ^a   Sinigaglia, Francesco ^a   Adorini, Luciano ^a  

^a BioXell SpA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CHEMOKINE; INTERLEUKIN 2 RECEPTOR;

CELLULAR DISTRIBUTION; IMMUNE RESPONSE; IMMUNOLOGICAL TOLERANCE; IMMUNOMODULATION; REVIEW; SUPPRESSOR CELL; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; TISSUE DISTRIBUTION;

EID: 0037374231     PISSN: 14714906     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1471-4906(03)00027-9     Document Type: Review

References (45)

1. + regulatory T cells: their common role in controlling autoimmunity, tumor immunity and transplantation tolerance. Immunol. Rev. 182:2001;18-32.
2. Karim M., et al. Regulatory T cells in transplantation. Curr. Opin. Immunol. 14:2002;584-591.
3. + suppressor T cells: more questions than answers. Nat. Rev. Immunol. 2:2002;389-400.
4. Roncarolo M.G., et al. Type 1 T regulatory cells. Immunol. Rev. 182:2001;68-79.
5. Singh B., et al. Control of intestinal inflammation by regulatory T cells. Immunol. Rev. 182:2001;190-200.
6. Nakamura K., et al. Cell contact-dependent immunosuppression by CD4(+)CD25(+) regulatory T cells is mediated by cell surface-bound transforming growth factor-β J. Exp. Med. 194:2001;629-644.
7. Piccirillo C.A., et al. CD4(+)CD25(+) regulatory T cells can mediate suppressor function in the absence of transforming growth factor-β1 production and responsiveness. J. Exp. Med. 196:2002;237-246.
8. Jonuleit H., et al. Infectious tolerance: human CD25(+) regulatory T cells convey suppressor activity to conventional CD4(+) T helper cells. J. Exp. Med. 196:2002;255-260.
9. Dieckmann D., et al. Human CD4(+)CD25(+) regulatory, contact-dependent T cells induce interleukin-10-producing, contact-independent type 1-like regulatory T cells. J. Exp. Med. 196:2002;247-253.
10. Butcher E.C., et al. Lymphocyte trafficking and regional immunity. Adv. Immunol. 72:1999;209-253.
11. Kunkel E.J., Butcher E.C. Chemokines and the tissue-specific migration of lymphocytes. Immunity. 16:2002;1-4.
12. Iellem A., et al. Unique chemotactic response profile and specific expression of chemokine receptors CCR4 and CCR8 by CD4(+)CD25(+) regulatory T cells. J. Exp. Med. 194:2001;847-853.
13. Annunziato F., et al. Phenotype, localization and mechanism of suppression of CD4(+)CD25(+) human thymocytes. J. Exp. Med. 196:2002;379-387.
14. Bystry R.S., et al. B cells and professional APCs recruit regulatory T cells via CCL4. Nat. Immun. 2:2001;1126-1132.
15. + splenocytes that delays adoptive transfer of diabetes expresses L-selectin and high levels of CCR7. J. Immunol. 169:2002;2461-2465.
16. Schaniel C., et al. Activated murine B lymphocytes and dendritic cells produce a novel CC chemokine, which acts selectively on activated T cells. J. Exp. Med. 188:1998;451-463.
17. Schaniel C., et al. A novel CC chemokine ABCD-1, produced by dendritic cells and activated B cells, exclusively attracts activated T lymphocytes. Curr. Top. Microbiol. Immunol. 246:1999;95-101.
18. Sallusto F., et al. Distinct patterns and kinetics of chemokine production regulate dendritic-cell function. Eur. J. Immunol. 29:1999;1617-1625.
19. Tang H.L., Cyster J.G. Chemokine upregulation and activated T-cell attraction by maturing dendritic cells. Science. 284:1999;819-822.
20. Selvan R.S., et al. Regulation of I-309 gene expression in human monocytes by endogenous interleukin-1. Eur. J. Immunol. 27:1997;687-694.
21. Iellem A., et al. Inhibition by IL-12 and IFN-α of I-309 and macrophage-derived chemokine production upon TCR triggering of human Th1 cells. Eur. J. Immunol. 30:2000;1030-1039.
22. Chang C.C., et al. Tolerization of dendritic cells by Ts cells: the crucial role of inhibitory receptors ILT3 and ILT4. Nat. Immun. 3:2002;237-243.
23. Lechler R., et al. Dendritic cells in transplantation - friend or foe? Immunity. 14:2001;357-368.
24. Mantovani A., et al. Macrophage-derived chemokine (MDC). J. Leukoc. Biol. 68:2000;400-404.
25. Anderson C.F., Mosser D.M. A novel phenotype for an activated macrophage: the type 2 activated macrophage. J. Leukoc. Biol. 72:2002;101-106.
26. Columba-Cabezas S., et al. Induction of macrophage-derived chemokine/CCL22 expression in experimental autoimmune encephalomyelitis and cultured microglia: implications for disease regulation. J. Neuroimmunol. 130:2002;10-21.
27. Shortman K., Liu Y.J. Mouse and human dendritic-cell subtypes. Nat. Rev. Immunol. 2:2002;151-161.
28. Moser M., Murphy K.M. Dendritic-cell regulation of Th1-Th2 development. Nat. Immun. 1:2000;199-205.
29. Lanzavecchia A., Sallusto F. Regulation of T-cell immunity by dendritic cells. Cell. 106:2001;263-266.
30. Penna G., et al. Differential chemokine production by myeloid and plasmacytoid dendritic cells. J. Immunol. 169:2002;6673-6676.
31. Jonuleit H., et al. Induction of interleukin-10-producing, nonproliferating CD4(+) T cells with regulatory properties by repetitive stimulation with allogeneic immature human dendritic cells. J. Exp. Med. 192:2000;1213-1222.
32. Mellman I., Steinman R.M. Dendritic cells: specialized and regulated antigen-processing machines. Cell. 106:2001;255-258.
33. Steinman R.M., Nussenzweig M.C. Avoiding horror autotoxicus: the importance of dendritic cells in peripheral T-cell tolerance. Proc. Natl. Acad. Sci. U. S. A. 99:2002;351-358.
34. Lutz M.B., Schuler G. Immature, semi-mature and fully mature dendritic cells: which signals induce tolerance or immunity? Trends Immunol. 23:2002;445-449.
35. Scheinecker C., et al. Constitutive presentation of a natural tissue autoantigen exclusively by dendritic cells in the draining lymph node. J. Exp. Med. 196:2002;1079-1090.
36. Penna G., Adorini L. 1,25-dihydroxyvitamin D3 inhibits differentiation, maturation, activation and survival of dendritic cells leading to impaired alloreactive T-cell activation. J. Immunol. 164:2000;2405-2411.
37. 3 and mycophenolate mofetil treatment mediate transplantation tolerance. J. Immunol. 167:2001;1945-1953.
38. Gregori S., et al. A 1α,25-dihydroxyvitamin D(3) analog enhances regulatory T cells and arrests autoimmune diabetes in NOD mice. Diabetes. 51:2002;1367-1374.
39. Bonecchi R., et al. Differential expression of chemokine receptors and chemotactic responsiveness of Th1 and Th2 cells. J. Exp. Med. 187:1998;129-134.
40. + T cells represent major subsets of human peripheral-blood memory T cells migrating in response to CCL1/I-309. Eur. J. Immunol. 32:2002;3506-3514.
41. Campbell J.J., et al. The chemokine receptor CCR4 in vascular recognition by cutaneous but not intestinal memory T cells. Nature. 400:1999;776-780.
42. Kim S.H., et al. CCR4-bearing T cells participate in autoimmune diabetes. J. Clin. Invest. 110:2002;1675-1686.
43. D'Ambrosio D., et al. Selective upregulation of chemokine receptors CCR4 and CCR8 upon activation of polarized human type 2 T helper cells. J. Immunol. 161:1998;5111-5115.
44. Colantonio L., et al. Modulation of chemokine receptor expression and chemotactic responsiveness during differentiation of human naïve T cells into Th1 or Th2 cells. Eur. J. Immunol. 32:2002;1264-1273.
45. Kim C.H., et al. Rules of chemokine receptor association with T-cell polarization in vivo. J. Clin. Invest. 108:2001;1331-1339.